White House Plans to Replace FDA Commissioner Marty Makary
Makary's tenure has been marked by criticism regarding his leadership of the agency responsible for drug and vaccine approvals.
The White House is planning to replace Marty Makary as the head of the Food and Drug Administration (FDA). Makary has been the commissioner of the agency since last year.
His time leading the FDA has been met with criticism. Many have raised concerns about his management style and the agency's direction under his leadership.
The FDA is a crucial government body. It is responsible for approving new drugs and vaccines. It also oversees food safety standards in the United States.
Sources familiar with the matter indicated that the White House is actively seeking a replacement. This move comes as the agency navigates internal challenges and public scrutiny.
The exact reasons for the planned replacement were not immediately clear. However, reports suggest ongoing turmoil within the agency has contributed to the decision.
Reporting incorporates material from a third-party source. Original
